BridgeMD
New treatment option for Shoulder Arthritis
Official title Study of Personalized Instrument in Total Shoulder Arthroplasty The P.I.T.S.A. Study
ClinicalTrials.gov ID: NCT03839758
What this study is testing
- What it's testing
- Total shoulder arthroplasty is an effective procedure to improve patients function and to relieve shoulder pain in cases of glenohumeral arthritis. The main challenge of this procedure is implanting the glenoid component.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Patients with shoulder osteaoarthritis and AVN
You likely can't join if
- Patients with previous shoulder arthroplasty
- Patients with inflammatory arthritis and tumor
- Patients with previous shoulder surgery with metal implant
- Patients refusing 2-year follow-up
- Patients that does not speak English or French
- Patients with current or previous shoulder infection
See the full eligibility criteria
- Patients with shoulder osteaoarthritis and AVN
- Patients with previous shoulder arthroplasty
- Patients with inflammatory arthritis and tumor
- Patients with previous shoulder surgery with metal implant
- Patients refusing 2-year follow-up
- Patients that does not speak English or French
- Patients with current or previous shoulder infection
- Patients with graft during surgery
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.